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ABSTRACT 
In pathological left ventricular hypertrophy (LVH) with a normal intrinsic 
myocardial function, eccentric chamber remodelling (cardiac dilatation) can produce a 
right shift in systolic pressure-volume (P-V) relations (systolic chamber dysfunction). 
Whether comparable degrees of cardiac dilatation in physiological (exercise-induced 
eccentric left ventricular remodelling) and pathological LVH produce similar effects on 
chamber function has not been determined. Hence, the aim of my thesis was to determine 
the impact of cardiac dilatation on systolic chamber function in chronically exercised rats 
with comparable increases in cardiac diastolic volumes as those produced by two rat 
models of pathological dilatation. 
Methods: Two models of cardiac dilatation were used, namely: (1) a model of 
pathological cardiac hypertrophy and dilatation (induced by chronic β-adrenoreceptor 
agonist administration to either Sprague-Dawley or spontaneously hypertensive rats), and 
(2) a model of physiological cardiac hypertrophy and dilatation (induced in Sprague-
Dawley rats by 4-5 months of voluntary running activity on exercise wheels). 33 
Sprague-Dawley rats were placed on spontaneous running wheels for 4-5 months (Exer 
group) and 24 Sprague-Dawley sedentary control rats (Con group) were placed 
individually in normal rat cages. To induced pathological dilatation, the β-agonist, 
isoproterenol (ISO) was administered daily to Sprague-Dawley rats for 7 months (SD-
ISO, n=10) and to spontaneously hypertensive rats (SHR) for 4-5 months (SHR+ISO, 
n=22). Saline was administered daily to controls (SD, n=10; SHR, n=21) and to 
normotensive Wistar Kyoto rats (WKY, n=17). In isolated, perfused heart preparations, 
left ventricular (LV) dilatation was determined from the diastolic pressure-volume (P-V) 
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relation and the volume intercept of the diastolic P-V relation (LV V0). Systolic chamber 
function was assessed by comparing LV developed pressures at specific filling volumes. 
Intrinsic systolic myocardial function was determined from the slope of the LV systolic 
developed stress-strain relation (myocardial systolic elastance). 
Results: ISO adminstered to SD and to SHR rats produced cardiac dilatation [LV 
V0 (ml): SD 0.20±0.01, SD-ISO 0.27±0.02, p<0.005; SHR 0.21±0.01, SHR-ISO 
0.30±0.01, p<0.001], systolic chamber dysfunction (decrease in left ventricular developed 
pressures at incremental filling volumes) but normal intrinsic systolic myocardial 
function. Habitual exercise resulted in a right shifted LV diastolic P-V relation and an 
increased LV V0 (Exer 0.22±0.01, Con 0.18±0.01, p<0.005). In exercised rats (Exer-
dilated, n=10) with equivalent dilatation as SD-ISO and SHR-ISO (LV V0 within 95% CI 
of SD-ISO and SHR-ISO), despite comparable LV diastolic P-V relations and LV V0 
values (0.28±0.01); both systolic chamber function and intrinsic systolic myocardial 
function were normal. 
Conclusions: These data provide evidence to indicate that as compared to 
pathological dilatation, a similar extent of exercise-induced dilatation does not produce 
the same adverse effects on systolic chamber function.  
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PREFACE 
It is generally perceived that regular exercise is beneficial to the cardiovascular 
system. However, as exercise is recognized as a factor that promotes the development of 
cardiac hypertrophy, a change that in pathological states such as hypertension has adverse 
prognostic implications, whether exercise has deleterious effects on the heart has in the 
past and is now again being questioned. It is presently acknowledged that exercise-
induced cardiac hypertrophy does not appear to predict adverse cardiovascular outcomes 
and may not be associated with the progression to cardiac dysfunction. In contrast to 
cardiac hypertrophy which occurs in pathological states (pathological hypertrophy), 
exercise-induced cardiac hypertrophy is thought to be a compensatory response to the 
normal demands of activity and as such is called “physiological cardiac hypertrophy”. 
However, with respect to physiological cardiac hypertrophy, regular, sustained, 
medium-to-high intensity exercise programs may induce cardiac hypertrophy with a 
geometric change that may not maintain wall stress during exercise-induced increases in 
blood pressure and chamber filling. Indeed, in this form of exercise the cardiac chamber 
increases in size to accommodate continuously high pre- and after-loads and this cardiac 
geometric change is reminiscent of cardiac dilatation in chronic heart failure, where a 
greater cavity size predicts a worse clinical outcome. As cardiac chamber dilatation 
contributes to pump dysfunction in heart failure and subsequent end stage heart failure, 
the question that arises is whether increases in cardiac cavity size in exercise-induced 
cardiac hypertrophy also promote pump dysfunction? 
In this regard, presently there is little understanding of the pathophysiological 
significance of increases in cardiac cavity size in exercise-induced cardiac hypertrophy. 
Although a reduced pump function has been noted to occur with increased cavity 
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dimensions in endurance athletes, whether the dilated chamber promotes pump 
dysfunction or is the consequence of alternative changes such as a reduced contractile 
function and heart rate or an increased preload, is unclear. 
This dissertation is aimed at attempting to understand the pathophysiological 
relevance of increases in cardiac cavity size in exercise-induced cardiac hypertrophy. As 
a major pathophysiological change thought to be responsible for cardiac dilatation in 
heart failure is excessive sympathetic nervous system activation, in the present 
dissertation I compared the impact of exercise-induced cardiac dilatation on pump 
function to that of cardiac dilatation induced by sympathetic over-activation (pathological 
dilatation). Importantly, I assessed whether pump dysfunction occurs in rats with 
exercise-induced cardiac dilatation the extent of which is comparable with that produced 
by pathological dilatation.  
